1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Finland Pharmaceuticals and Healthcare Report Q3 2016

Finland Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 67 pages

Includes 3 FREE quarterly updates

BMI View: Finland's economy is set to expand at the slowest rate in the eurozone in 2017. Reforms aimedat tackling its uncompetitive labour market will be insufficient to solve its bleak economic situation. Thiswill force the government to make cost savings, with the pharmaceutical and healthcare sectors primarytargets for this, as both are large beneficiaries of public funds. However, Finland will still continue to beone the wealthiest countries in the world in terms of real GDP per capita, and this will - along with anaging population - maintain sales of high-value pharmaceuticals over the longer term.

Headline Expenditure Projections

- Pharmaceuticals: EUR2.98bn (USD3.30bn) in 2015 to EUR3.09bn (USD3.31bn) in 2016;+3.8% inlocal currency terms and +0.1% in US dollar terms. Forecast revised upwards slightly from last quarter.

- Healthcare: EUR19.50bn (USD21.63bn) in 2015 to EUR20.10bn (USD21.51bn) in 2016; +3.1% in localcurrency terms and -0.6% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Finland Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Finland 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Finland 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Finland 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Finland 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Finland 2014-2020) 27
Industry Risk/Reward Index 28
Western Europe Risk/Reward Index 28
Finland Risk/Reward Index 33
Rewards 33
Risks 33
Regulatory Review 35
Intellectual Property Issues 36
Pricing Regime 36
Reimbursement Regime 39
Market Overview 41
Healthcare Sector 42
Table: Healthcare Resources (Finland 2010-2015) 45
Table: Healthcare Personnel (Finland 2010-2015) 46
Table: Healthcare Activity (Finland 2010-2015) 46
Research And Development 46
Clinical Trials 47
Epidemiology 48
Competitive Landscape 52
Research-Based Industry 52
Table: Multinational Market Activity 53
Table: PIF Members 54
Generic Drugmakers 55
Pharmaceutical Distribution and Retail Sector 55
Demographic Forecast 56
Table: Population Headline Indicators (Finland 1990-2025) 57
Table: Key Population Ratios (Finland 1990-2025) 57
Table: Urban/Rural Population and Life Expectancy (Finland 1990-2025) 58
Table: Population By Age Group (Finland 1990-2025) 58
Table: Population By Age Group % (Finland 1990-2025) 59
Glossary 61
Methodology 63
Pharmaceutical Expenditure Forecast Model 63
Healthcare Expenditure Forecast Model 63
Notes On Methodology 64
Risk/Reward Index Methodology 65
Index Overview 66
Table: Pharmaceutical Risk/Reward Index Indicators 66
Indicator Weightings 67

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.